At the mRNA and protein levels, enhanced expression of SDF-1 and CXCR4 has been demonstrated in different malignancies, including epithelial ovarian cancer and ovarian cancer cell lines (7–12). This evidence concerns the gene CXCL12 and ovarian carcinoma.